R. Gregory Bociek, M.D.
Associate Professor, Internal Medicine
Division of Oncology & Hematology
Academic office mailing address:
UNMC Oncology/Hematology Division
986840 Nebraska Medical Center
Omaha, NE 681980-6840
Main Academic Ph. 402-559-8500
New Patient Referral Ph. 402-559-5600
Fred & Pamela Buffett Cancer Center
505 South 45th Street
Omaha, NE 68105 (map)
Nebraska Medicine Village Pointe
111 North 175th Street
Omaha, NE 68118
Ph. 402-596-3100 (map)
Sep. 1982-June 1984: B. Sc. Biology, Queen's University, Kingston, Ontario, Canada
Sep. 1984-May 1988: Medical Degree, University of Ottawa
July 1988-June 1991: Residency, Internal Medicine, University of Ottawa
July 1991-June 1993: Fellowship, Medical Oncology,
July 1991-June 1993: Chief Resident, Medical Oncology, University of Ottawa
July 1993-June 1994: Fellowship, Bone Marrow Transplantation, University of Nebraska Medical Center
Sep. 1994-June 1996: Clinical Scholar, University of Ottawa
June 1999: Masters in Clinical Epidemiology of Science, University of Ottawa
Dr. Bociek is an Associate Professor and has been on faculty at UNMC since 1998. Dr. Bociek completed his residency and fellowship training in oncology at the University of Ottawa and bone marrow transplantation training at the University of Nebraska Medical Center. He also completed a master degree in Clinical Epidemiology. Dr. Bociek's expertise is in the treatment of patients with lymphoma. Dr. Bociek is the current Program Director of Hematology/Oncology Fellowship Program at UNMC. Dr. Bociek is involved in various clinical trials in patients with lymphoma. He enjoys interacting with students and is involved in various research activities at UNMC. He reviews for various journals in hematology and oncology.
Mitrovic Z, Bast M, Bierman PJ, Bociek RG, Vose JM, Chan WC, Armitage JO. The addition of rituximab reduces the incidence of secondary central nervous system involvement in patients with diffuse large B-cell lymphoma. Br J Haematol, 157(3):401-403, 2012.
Gilling CE, Mittal AK, Chaturvedi NK, Iqbal J, Aoun P, Bierman PJ, Bociek RG, Weisenburger DD, Joshi SS. Lymph node-induced immune-tolerance in chronic lymphocytic leukaemia: a role for caveolin-1. Br J Haematol 158(2):216-31, 2012.
Vose JM, Bierman PJ, Loberiza FR, Enke C, Hankins J, Bociek RG, Chan WC, Weisenburger DD, Armitage JO. Phase II Trial of 131-Iodine Tositumomab with high-dose chemotherapy and autologous stem cell transplantation for relapsed diffuse large-B-cell lymphoma. Biol Blood Marrow Transplant 2012 Aug 29 [E pub ahead of print].
Vose JM, Bierman PJ, Loberiza FR, Enke C, Hankins J, Bociek RG, Chan WC, Weisenburger DD, Armitage JO. Phase II trial of 131-iodine tositumomab with high-dose chemotherapy and autologous stem cell transplantation for relapsed diffuse large B-cell lymphoma. Biol Blood Marrow Transplant; 19(1):123-128, 2013.
William BM, Loberiza Jr., FR, Whalen V, Bierman PJ, Bociek RG, Vose JM, Armitage JO. Impact of conditioning regimen on outcome of 2-year disease-free survivors of autologous stem cell transplantation for Hodgkin lymphoma. Clin Lymphoma Myeloma Leuk; 13:417-423, June 14, 2013.
Mittal AK, Chaturvedi NK, Rohlfsen RA, Gupta P, Joshi AD, Hegde GV, Bociek RG, Joshi SS. Role of CTLA4 in the proliferation and survival of chronic lymphocytic leukemia. PLoS One, 1:8(8):e70352, August, 2013.
William BM, Allen MS, Loberiza FR, Bociek RG, Bierman PJ, Armitage JO, Vose JM. Phase I/II study of Bortezomib-BEAM and autologous hematopoietic stem cell transplantation for relapsed indolent non-Hodgkin lymphoma transformed or mantle cell lymphoma. Biol Blood Marrow Transplant,20(4): 536-542, 2014.
Bhatt VR, Akhtari M, Bociek G, Sanmann J, Uyan J, Dave BJ, Sanger W, Kessinger A, Armitage J. Allogeneic stem cell transplantation for Philadelphia chromosome-positive Acute myeloid leukemia. J Natl Compr Canc Netw, 2014. PMID 24305719
Mittal AK, Chaturvedi NK, Rai KJ, Gilling-Cutucache CE, Nordgren TM, Moragues M, Lu R, Opavsky R, Bociek GR, Weisenburger DD, Iqbal J, Joshi SS. Chronic Lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease. Mol Med. 20, 290-301, 2014. 24800836
Bhatt VR, Bociek RG, Yuan J, Fu K, Greiner TC, Dave BJ, Rajan SK, Armitage JO. Leukemic diffuse large B-cell lymphoma in a patient with myeloproliferative disorder. J Natl Compr Canc Netw; 13(3): 281-287, Mar 2015. 25736004
Additional Publications at PubMed.Gov: https://www.ncbi.nlm.nih.gov/pubmed